These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31025490)

  • 81. The Clinical Outcomes After Intratympanic Gentamicin Injection to Treat Menière's Disease: A Meta-analysis.
    Zhang Y; Fu J; Lin H; Shen C; Wang X; Wu J
    Otol Neurotol; 2019 Apr; 40(4):419-429. PubMed ID: 30870347
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Delayed Effect and Gain Restoration After Intratympanic Gentamicin for Menière's Disease.
    Martin-Sanz E; Diaz JY; Esteban-Sanchez J; Sanz-Fernández R; Perez-Fernandez N
    Otol Neurotol; 2019 Jan; 40(1):79-87. PubMed ID: 30334870
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Modified titration intratympanic gentamicin injection for unilateral intractable Ménière's disease.
    Liu B; Leng YM; Shi H; Zhou RH; Liu JJ; Zhang WJ; Zhang SL; Kong WJ
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):747-751. PubMed ID: 26489633
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial.
    Stokroos R; Kingma H
    Acta Otolaryngol; 2004 Mar; 124(2):172-5. PubMed ID: 15072419
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Intratympanic gentamicin treatment for unilateral Ménière's disease: long-term follow up of a proven regime.
    Wasson J; Upile N; Pfleiderer A
    J Laryngol Otol; 2013 Jan; 127(1):20-4. PubMed ID: 23217984
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Gentamicin for the transtympanic treatment of Menière's disease].
    Ma Y; Zhou X; Wang W
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):444-5. PubMed ID: 12541687
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin.
    Quaranta A; Scaringi A; Aloidi A; Quaranta N; Salonna I
    Acta Otolaryngol; 2001 Apr; 121(3):387-92. PubMed ID: 11425206
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Response to: Comparison of intratympanic methylprednisolone and gentamicin for Meniere's disease may be misleading.
    Gabra N; Saliba I
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):175-6. PubMed ID: 23818541
    [No Abstract]   [Full Text] [Related]  

  • 91. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE; Kamerer DB
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intratympanic corticosteroids in Ménière's disease: A mini-review.
    Patel M
    J Otol; 2017 Sep; 12(3):117-124. PubMed ID: 29937846
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of intratympanic injection of latanoprost in Meniere's disease: a randomized, placebo-controlled, double-blind, pilot study.
    Rask-Andersen H; Friberg U; Johansson M; Stjernschantz J
    Otolaryngol Head Neck Surg; 2005 Sep; 133(3):441-3. PubMed ID: 16143197
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Intratympanic Therapies for Menière's disease.
    Miller MW; Agrawal Y
    Curr Otorhinolaryngol Rep; 2014 Sep; 2(3):137-143. PubMed ID: 25215266
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.
    Driscoll CL; Kasperbauer JL; Facer GW; Harner SG; Beatty CW
    Laryngoscope; 1997 Jan; 107(1):83-9. PubMed ID: 9001270
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparison of intratympanic methylprednisolone and gentamicin for Meniere's disease may be misleading.
    Crane BT
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):175. PubMed ID: 23818540
    [No Abstract]   [Full Text] [Related]  

  • 99. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK; Sandooram D; Prinsley PR
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.
    Bodmer D; Morong S; Stewart C; Alexander A; Chen JM; Nedzelski JM
    Otol Neurotol; 2007 Dec; 28(8):1140-4. PubMed ID: 18084826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.